Skip to main content
Tech.euFundingExplorerBeta

Protembis

A medical technology company that develops devices to reduce the risk of brain lesions and stroke during cardiology procedures such as transcatheter aortic valve replacement.

Protembis has raised €59M across 3 funding rounds from 10 investors, most recently a Debt round in Jul 2024. Based in Aachen, Germany; founded 2013; active in Healthtech. Data as of 28 Oct 2026.

Aachen, GermanyFounded 2013www.protembis.com ↗
Total raised
€59M
€58,638,563
Funding rounds
3
Investors
10
distinct backers
Active since
2018-10
latest 2024-07

Funding by year

EUR raised per year
Protembis — funding by year — interactive chart.
Data table
Protembis — funding by year
2018€8.6M
2024€50M

Signals

High confidence
Raise-next likelihood7
base rate 45% for Debt
  • ▼ Dormant (no round in 3+ cohort gaps)
  • ▼ Down/flat last round
  • ▼ Low backer re-investment
Exit likelihood10
base rate 11% (2+ rounds)
  • ▲ €30M+ raised
  • ▼ No recent equity round (debt-only or quiet)

Timing: dormant vs cohort gap · momentum down. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

3 rounds

Similar companies

same sector or country

Global coverage: FundingData